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Processivity in Bacterial Glycosyltransferases
Liubov Yakovlieva and Marthe T. C. Walvoort*
Stratingh Institute for Chemistry, University of Groningen, 9747 AG Groningen, The Netherlands
ABSTRACT: Extracellular polysaccharides and glycoproteins of pathogenic bacteria
assist in adherence, autoaggregation, biofilm formation, and host immune system
evasion. As a result, considerable research in the field of glycobiology is dedicated to
study the composition and function of glycans associated with virulence, as well as
the enzymes involved in their biosynthesis with the aim to identify novel antibiotic
targets. Especially, insights into the enzyme mechanism, substrate binding, and
transition-state structures are valuable as a starting point for rational inhibitor design.
An intriguing aspect of enzymes that generate or process polysaccharides and
glycoproteins is the level of processivity. The existence of enzymatic processivity reflects the need for regulation of the final
glycan/glycoprotein length and structure, depending on the role they perform. In this Review, we describe the currently
reported examples of various processive enzymes involved in polymerization and transfer of sugar moieties, predominantly in
bacterial pathogens, with a focus on the biochemical methods, to showcase the importance of studying processivity for
understanding the mechanism.
■ INTRODUCTION
High-molecular-weight polysaccharides are central constituents
of the cell wall and extracellular matrix in all domains of life.
Well-known examples include the homopolymers cellulose and
chitin, and heteropolymers such as hyaluronic acid and other
glycosaminoglycans. In eukaryotes, these extracellular poly-
saccharides are important for cellular integrity and cell−cell
communication, while in bacteria they are part of the cell wall,
membranes, capsule, and/or biofilm that forms as a defense
mechanism from the host or a potentially hostile environment.
Similar to the enzymes working on other natural biopolymers,
such as DNA polymerase, protein translation by the ribosome,
and protein kinases, many glycan-processing enzymes that
synthesize and degrade these polysaccharides have a distinct
mechanistic feature in common: they display (a degree of)
processivity. A processive mechanism (Figure 1A) is charac-
terized by a high binding affinity of the enzyme for the (growing)
product chain, so that it stays associated during multiple rounds
of catalysis yielding longer polymers or more uniform
modifications. On the other end of the spectrum is the
distributive mechanism (Figure 1B), where the enzyme
performs one round of catalysis during every single binding
event, which typically leads to a distribution of products. In a
sense, processivity is Nature’s way of ensuring the desired
polymer length is produced with high fidelity and accuracy. It is
important, for example, in DNA synthesis, where the associated
polymerases are found to bind tightly to the growing substrate
and are highly processive.1,2 Because only a few classes of
enzymes are strictly processive or distributive, thesemechanisms
are the two opposite ends of a continuum. Most polymerizing
enzymes display a certain degree of processivity (so-called
“apparent processivity”), which may be influenced by the nature
of the substrate, or external factors such as substrate
concentrations or membrane translocation machinery, and can
be seen as the actual processivity of the enzyme under certain
conditions. An alternative description is the theoretical “intrinsic
processivity” (vide inf ra).3 Originally developed for nucleic acid
polymerases, it is defined as the distribution of probabilities that
the enzyme will stay associated and catalyze another reaction,
rather than dissociate from the intermediate product.
Processive mechanisms have been identified in a multitude of
enzyme families, notably the DNA polymerases, exonucleases,5
ribosomal protein translation machinery,6 ubiquitin ligases,7−9
kinases,10,11 motor enzymes like kinesin,12 glycosidases,13 and
glycosyltransferases (vide inf ra). Interestingly, these enzymes
catalyze chemically different reactions, such as polymerization,
degradation, and decoration, but all share certain mechanistic
and structural characteristics to be called “processive”. For
instance, there are several structural features that promote
processivity,14 including the ability to form an inclusion complex
with the growing substrate by enzyme domain multimerization,
or having a flexible polypeptide patch that closes upon substrate
binding.15 Alternatively, high binding affinities are accomplished
by large acceptor substrate-binding grooves that also promote
sliding of the growing chain along the template, as is the case
with chitin hydrolases.16
Processivity is a challenging mechanistic feature to exper-
imentally investigate, and researchers have developed manifold
methods to determine the degree of processivity of a plethora of
enzymes.3 In the field of glycan-processing enzymes, seminal
reports exist on the processivity of various glycosyltransferases
and hydrolases, which have been reviewed recently.17,18 Also
glycan-modifying enzymes, such as alginate and dermatan
sulfate epimerases, show processive characteristics.19,20 In this
Review, we focus on the enzymes involved in bacterial
polysaccharide and glycoprotein synthesis. Polysaccharides,
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glycans, and glycoconjugates are synthesized by dedicated
glycosyltransferases (GTs), a family of enzymes that transfer a
specific carbohydrate residue from a nucleotide- or lipid-
pyrophosphate-activated donor to a certain carbohydrate,
lipid, or protein acceptor substrate. This is an experimentally
challenging class of enzymes that are all involved in the
production of bacterial structures that are important in
pathogenicity (Figure 2). Interestingly, bacteria-specific glyco-
sylation of various crucial cell components presents a unique
opportunity for species-targeted drug development because of
their unique sugar structures and the resulting lack of cross-
reactivity with human glycosylation systems.21 As the bacterial
glycans are assembled by bacteria-specific GTs, there is a wealth
of possible targets for which inhibitors can be generated.
However, because of the relatively young field of bacterial
glycosylation, the precise molecular mechanisms of many
bacterial GTs remain to be elucidated in detail to enable the
rational development of inhibitors.22
To aid in the identification of processive characteristics in
bacterial GTs, we discuss experimental methods to determine
GT processivity and present current examples where these
methods are used to study processivity of bacterial polymerizing
GTs, semiprocessive GTs, and protein GTs. Also examples in
which knowledge of processive behavior inspired inhibitor
design are presented. As the characteristics of processive GTs
are as diverse as the products they synthesize, it is hard to
generalize and predict processivity. However, the integrative
table at the end of this Reviewmay assist in discerning processive
features, which may be further identified using the methods
described here.
■ METHODS TO STUDY PROCESSIVITY
The majority of the experiments that are aimed at unraveling
processivity in enzymatic catalysis are performed in vitro. A mixture
of the GT enzyme under study, together with the nucleotide-activated
carbohydrate donor and a suitable acceptor (glycan, protein, lipid) are
mixed. As the product distribution and kinetic profile will be
significantly different between a processive and distributive mechanism,
they are generally assessed at specific time points (Figure 3A).
Product Distribution. The degree of processivity is often deduced
from the distribution of product lengths. For template-mediated
polymerization, such as nucleic acid polymerization, the product length
is determined by the template strand. In nontemplated polymerization,
as is the case for glycosyltransfer reactions, the degree of processivity is
largely determined by the binding affinity of the enzyme to the growing
chain or resulting product. Analysis of the glyco- or proteoforms present
at certain time points can provide insight into processivity/
distributivity (Figure 3A). In the case of a processive enzyme, a gradual
decrease of acceptor substrate and concomitant fast increase of product
length may be observed over time, while the levels of intermediate
products remain marginal (Figure 3B). A distributive process will yield
a distinctly different pattern, with a rapid disappearance of the acceptor
substrate and simultaneous appearance of several “early” glyco- or
proteoforms that are all gradually converted over time. Processivity is
also inferred by prolonged persistence of unmodified acceptor
substrate, which may reflect the high affinity of the enzyme for its
substrate and/or occurrence of enzyme−substrate covalent intermedi-
ate. Visualization of the product distribution is most commonly
performed using techniques such as gel electrophoresis (SDS or native
PAGE), thin-layer chromatography (TLC), and (liquid-chromatog-
raphy-coupled) mass spectrometry (LC-MS).
Kinetics. A useful method of determining the degree of processivity
in a quantitative manner is by measuring the kinetic parameters koff and
kcat. One of the hallmarks of processivity is a strong enzyme−substrate
(enzyme-intermediate) association, which can be converted into
numerical values of the dissociation rate (koff), whereas kcat indicates
the efficiency of acceptor substrate turnover. Combined in a formula
(Figure 3C), these parameters give the intrinsic processivity Pintr of the
enzyme as the average number of catalytic acts performed before
dissociation.3 kcat is generally measured by performing enzyme kinetics
analysis, and koff can be estimated using techniques such as isothermal
titration calorimetry (ITC), surface plasmon resonance (SPR), and
biolayer interferometry. Another potential kinetic feature of processive
enzymes is an apparent lag phase at early reaction times. This lag is
attributed to the slow formation of the short products, so-called
“primers” at the beginning of the reaction, for which the enzyme has still
a low affinity. When the enzyme has a higher affinity for the partially
modified acceptor substrates as compared to the nonmodified
substrate, subsequent catalysis increases the substrate affinity, which
induces the processive fast phase and increases enzymatic turnover rate
and product formation.
Single Hit. Varying the enzyme-to-substrate ratios may lead to
further proof of processive behavior. Under so-called “single-hit
conditions”, the acceptor substrate is used in large excess compared
to the enzyme (typically in 1:100 or 1:500 ratio). A distributive enzyme
will quickly generate “early” products, since there is a higher chance of
binding an unmodified substrate molecule upon dissociation rather
than an intermediate molecule (Figure 3A, right). In contrast,
processive enzymes will remain associated with the bound acceptor
substrate and modify it to completion (Figure 3A, left). Therefore, the
presence of a final product under single-hit conditions is indicative of
processivity.
Distraction Assay. Another method that is linked to enzyme−
substrate association is the distraction assay (Figure 3D). As is evident
from the name, the enzyme is “distracted” from the reaction it is
performing by the addition of a new batch of (labeled) acceptor
Figure 1. Schematic representation of the two ends of the catalytic mechanism spectrum. (A) In a processive reaction mechanism, the GT enzyme
binds the acceptor substrate* and remains associated duringmultiple (n) rounds of catalysis; (B) In a distributive reactionmechanism, the GT enzyme
releases the growing substrate after every reaction and rebinds to perform the next reaction (hexagon = carbohydrate, NDP = nucleotide-diphosphate,
GT = glycosyltransferase, n = number of catalytic cycles). * In case the NDPmoiety stays attached to the growing substrate (not drawn here), it can be
involved in acceptor substrate binding during processivity, as is hypothesized for streptococcal hyaluronan synthase.4
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substrate or inhibitor (also called a “pulse-chase” experiment). The
product distribution analysis of a processive enzyme will reveal that
when the enzyme is still working on the first batch of substrate, addition
of a new batch will not lead to enzyme distraction. As a result, the
majority of final products will not contain the label (Figure 3D, left). In
the case of a distributive enzyme, the opposite effect is observed.
Because the enzyme does not stay associated with the growing substrate
or intermediates in-between catalysis rounds, both first and second
batches of substrate will have equal access to the enzyme, creating
products both with and without the label (Figure 3D, right).
As apparent from the examples presented below, the conclusion that
a certain enzyme is processive is often challenging to draw, and involves
performing several experiments using complementary methods. In
general, the first hint of a processive mechanism is the fact that a single
GT is involved in polymerization or multiple modifications of its
substrate. Processivity is often inferred from enzyme similarity to other
processive GTs in sequence, fold, function, or its association with the
translocation machinery. Subsequently, researchers generally start by
studying the structural features of the active site and substrate binding
motifs, or by determining the product profile from the in vitro reaction.
These experiments can be further supported quantitatively by
measuring the dissociation constants and kinetic parameters to prove
tight enzyme−substrate binding and calculate intrinsic processivity
values, respectively. When the results of the performed experiments are
ambiguous or paint a more complex picture (e.g., with semiprocessive
enzymes), more advanced methods can be used to prove the
mechanism. For instance, if an inhibitor or alternative substrate is
known for the enzyme of interest, it can be used in a distraction assay
(pulse-chase experiment) to prove the processive behavior. Alter-
natively, labeled substrate can be used in the same way to (dis)prove the
mechanism. Generally, for most GTs multiple methods are used to
prove processivity and unravel the inherent reasons for it.
Figure 2. Schematic picture of bacterial cell walls showing the polysaccharides and glycoproteins discussed in this Review, with their chemical
structures underneath. (A) peptidoglycan, (B)GspB adhesin, (C) wall teichoic acids, (D) cellubiuronic acid CPS, (E) CPSA, (F) CPSX, (G) polysialic
acid, (H) and (I) O-antigens, (J) TibA autotransporter, (K) galactan.
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Figure 3.Overview of the methods most often used to study processivity. (A) Theoretical outcomes of the reaction at times t when the mechanism is
processive (left) or distributive (right). (B) Analysis of product distributions by SDS-PAGE, TLC and (LC-)MS. (C) Kinetic analysis of the reaction
mechanism. (D) Experimental setup of a distraction assay, with the potential product profiles.
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■ PROCESSIVITY IN POLYMERIZING
GLYCOSYLTRANSFERASES
To produce the highly diverse pool of glycans present in all
domains of life, unique GTs are needed to catalyze a specific
reaction, and hundreds of known GTs have been classified into
GT families based on protein sequence similarities (see www.
cazy.org for an up-to-date overview of GT families).23 The
majority of mechanistic research has focused on the distinction
between an “inverting” and “retaining” mechanism, which refers
to the anomeric configuration of the new glycosidic bond in
relation to the linkage in the donor.24 Taking the glycosylation of
wall teichoic acids as an example (Figure 2), in an inverting
mechanism the anomeric configuration of the carbohydrate in
the nucleotide-activated donor (e.g. UDP-α-GlcNAc) is
opposite to the configuration in the product (e.g., β-GlcNAc
synthesis by TarS). In contrast, the anomeric linkage in the
donor and product are of the same configuration in a retaining
mechanism (α-GlcNAc synthesis by TarM). Another interesting
feature of GTs that produce polysaccharides is the direction of
elongation; new carbohydrate units may be added to the
reducing end (i.e., to the anomeric center of the acceptor
substrate), or to the nonreducing end of the growing chain.
Independent of the direction of elongation, the growing chain
may be linked at the reducing end to the nucleotide-diphosphate
moiety from the donor (as in hyaluronan synthase)4 or a lipid
moiety (as in peptidoglycan transferase, vide inf ra).
A prominent example of a processive glycosyltransferase is
cellulose synthase. Cellulose is the major constituent of the plant
cell wall, and also several bacterial species synthesize cellulose as
part of their biofilm formation. It is a linear polysaccharide that
consists of β-1→ 4 linked glucopyranosides, and lengths of up to
15 000 glucose units have been reported in plants.25 Cellulose is
synthesized by a membrane-integrated cellulose synthase
complex (CeS), which varies greatly between species but all
share a conserved catalytic subunit. CeS is an inverting GT that
is classified in the GT2 family, and it synthesizes cellulose by
adding Glc units from the UDP-Glc donor to the nonreducing
end of the growing substrate.26 Glycosylation is efficiently
coupled to translocation across the membrane, so that the
growing chain is immediately exported.27 Processivity is inferred
from kinetic analysis and the tight binding of the enzyme with
the acceptor substrate.28 More details on the mechanism of the
cellulose synthase enzymes can be found in a recent review.29
Next to the investigations into the processivity in cellulose
synthesis, processive mechanisms have been established for the
membrane-integrated synthases producing chitin30 and hyalur-
onan.31,32 The associated enzymes all belong to GT family 2 of
inverting β-glycosyltransferases, and they couple processive
polymerization at the membrane interface with translocation to
the extracellular space.26 More recently, with the increasing
awareness of the involvement of bacterial polysaccharides in
pathogenicity and virulence, the mechanisms of the GTs
responsible for the production of these bacterial structures
have received increasing attention. As shown below, these
reports reveal that processivity is a widespread mechanistic
feature that occurs across different GT families.
Peptidoglycan. Peptidoglycan (PG, structure A in Figure 2)
is a dense cross-linked layer of polysaccharides present in the cell
wall of all bacteria. PG is initially constructed as a linear polymer
of alternating GlcNAc (NAG) and MurNAc (NAM) residues,
which are in a later stage cross-linked by transpeptidases. The
linear PG is formed by the action of peptidoglycan transferase
(PG transferase, also called transglycosylase, GT family 51) in
the extracellular space that transfers an undecaprenyl-
pyrophosphate-linked NAG-NAM dimer (Lipid II) to the
reducing end of the growing lipid-linked NAG-NAM repeat.34
PG chain length varies tremendously between bacterial species,
and lengths of 3 to 250 disaccharide units have been reported,33
which seem to be a result of the nature of the PG transferase
enzyme instead of the enzyme to acceptor ratio.34 PG transferase
from Aquifex aeolicus was shown to operate through a processive
mechanism, as under steady-state conditions no small NAG-
NAM repeats were observed (gel-electrophoresis assay), but
instead, a ladder of up to 40 NAG-NAM repeats was visible.35
This in vitro experiment was complemented by structural
information that suggests that the PG transferase contains a
flexible helical “flap” that closes upon catalysis and retains the
growing PG chain in the active site. Moreover, a donor and
acceptor site cooperativity has been described, because the
enzyme flexibility is greatly reduced when both donor and
acceptor substrate are bound, which is proposed to aid in the
processive mechanism.36 The determination of structural
features in this case helps to understand the determinants of
processivity: the PG chain is locked in the active site allowing the
next repeating unit to be added, instead of product release. Also
the characteristic lag-phase was observed in a fluorescent kinetic
assay, which disappeared when the concentration of the first
catalytic product had increased.37 Alternatively, the lag-phase
also disappeared when synthetic Lipid IV (a Lipid II dimer) was
directly used as the donor, bypassing the first catalytic step.38
Together, knowledge of the structural elements that retain the
growing chain in the active site and the preference for more
elongated substrate provides strong support for processive
behavior. Recently, two new types of PG transferases, called
RodA and FtsW, were reported that belong to the Shape,
Elongation, Division, and Sporulation (SEDS)-family of
proteins.39−41 Initial hints at the catalytic mechanism have
started to appear (i.e., reducing-end elongation),42 so it will be
interesting to understand the degree of processivity of these
enzymes. Because PG transferase processivity has been
implicated as a mechanism to ensure bacterial cell straightening
after deformations caused by external stress, these enzymes have
a direct impact on bacterial fitness and antibiotic resistance.43,44
Wall Teichoic Acids. Wall teichoic acids (WTAs, structure
C in Figure 2) in Staphylococcus aureus consist of 40−60 repeats
of polyribitol phosphate, and are heavily decorated with O-
GlcNAc residues, which appear to be important for antibiotic
resistance and virulence.45 TheGlcNAc units are attached by the
GT enzymes TarM and TarS through an α- and β-linkage,
respectively (Figure 2). Using structural studies of both GTs in
complex with their substrates and products, it was deduced that
TarM and TarS form trimers.46,47 For the retaining enzyme
TarM, the trimerization did not seem to have an impact on
processivity, as the WT and a trimerization-impaired mutant
(G117R) showed equally high intrinsic processivity (Pintr 11 700
± 1200 and 12 800 ± 1100, respectively, obtained from
measuring kon and koff using biolayer interferometry).
46 The
authors propose that a positively charged groove in the acceptor-
binding domain is important for binding the negatively charged
acceptor substrate and facilitate its sliding during processive
GlcNAc transfer. Interestingly, the trimerization is more
important for the inverting enzyme TarS, as the wild-type
showed a Pintr of 2400 ± 260, compared with the truncated
enzyme lacking the trimerization domain, which showed a Pintr
of 133 ± 14, suggesting that the trimerization induced a
ACS Chemical Biology Reviews
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processive mechanism.47 This difference between TarM and
TarS is an intriguing discovery, and more research may shed
light on the contribution of trimerization to processivity.
Processivity may arise from the trimeric enzyme that modifies
multiple substrate molecules simultaneously or from the
geometry of the trimer that helps to thread the growing
substrate. Since the kinetic experiments were performed through
analysis of the amount of UDP released instead of identification
of product formed, the questions remain whether TarM and
TarS have a certain spatial preference of addingGlcNAc residues
and the precise direction of catalysis for the polyribitol
phosphate acceptor.
Capsular Polysaccharides. Bacterial capsular polysacchar-
ides (CPS) are highly diverse long-chain structures with a
repetitive nature that vary greatly between bacterial species and
serotypes (structures D−G in Figure 2).48,49 They form a dense
capsule aroundmany pathogenic bacteria and are both a first line
of defense and a virulence factor.
The CPS of Streptococcus pneumonia 3 is composed of
cellubiuronic acid (structure D in Figure 2), a polymer
containing [3-β-D-GlcA-(1 → 4)-β-D-Glc-(1 →] disaccharide
repeats, reaching sizes of 50−1150 kDa. The responsible
enzyme cellubiuronan synthase (Cps3S, or Cap3B) contains
the signature motif QXXRW that is also found in the
polymerases that produce cellulose, chitin, and hyaluronan,
which may be a first indication of potential processivity.17
Cellubiuronic acid is synthesized by the addition of carbohy-
drate residues to the nonreducing end in a processive
mechanism.50 Sps3S kinetics show a distinct lag phase during
which the enzyme is assumed to produce a lipid-linked
oligosaccharide of ∼4 dimer repeats,51 followed by the full
processive state in which rapid elongation is accomplished.
Initial hints for this processivity were obtained through a pulse-
chase experiment, in which an in vitro reaction was started with
isotopically labeled carbohydrate donor, followed by a pulse of
nonlabeled donor and a chase for 5 and 20 min.50 The majority
of labeled carbohydrates were incorporated in the longer
polymers, indicating a tight association between the enzyme and
the elongating product. When the reaction temperature was
increased to 54 °C, the fraction of polysaccharide was greatly
reduced while the contribution of shorter oligosaccharides had
increased, presumably because the rate of premature dissocia-
tion was higher at elevated temperatures.51 These experiments
strongly suggest a preference for elongated substrate and a tight
association, which are hallmark characteristics of a processive
enzyme. Structural information will complement these obser-
vations and may offer an explanation for the apparent processive
behavior.
The CPS structures of Neisseria meningitidis are negatively
charged, and in the case of the serogroups A and X, this is caused
by a phosphodiester moiety linking the carbohydrates
(structures E and F in Figure 2), resulting in the polymers
CPSA (poly-α-1→ 6-ManNAc-1-OPO3
−) and CPSX (poly-β-1
→ 4-GlcNAc-1-OPO3
−), respectively, which share a common
glycolipid membrane anchor with polysialic acid (vide inf ra).52
The biosynthesis of these polymers has received widespread
interest because of their antigenicity, which subsequently led to
their use in the development of synthetic vaccines.53−55 CPSX is
synthesized by the GlcNAc-transferase CsxA, which was shown
to act in a processive manner. When exposed to increasing ratios
of UDP-sugar donor and a short oligosaccharide acceptor, there
was a switch from the production of short to long products (gel
electrophoresis).55 This suggests an optimal donor/acceptor
ratio at which the tightly associated CsxA is able to produce
longer products. This could reflect optimal conditions to ensure
processivity in vivo, with access to CPS of defined lengths as a
result. In contrast, an increasing donor to acceptor ratio for
CsaB, responsible for synthesizing CPSA, resulted in a stepwise
increase in product size, suggesting it uses a distributive
mechanism. When compared with CsaB, processive CsxA
harbors an additional 98 amino acid residues at the C-terminus,
which proved to be essential for processivity, since the removal
of this section turned CsxA into a distributive enzyme, as further
illustrated by HPLC-AEC elution profiles of the products.55 It
was suggested that the C-terminal section of CsxA acts as a
product-binding domain, as a complex with the CPSX product
was resistant to proteolysis.55 Similarly to other examples, this
structural motif contributes to processivity by retaining the
product near the active site and allowing the enzyme to perform
the next round of catalysis. Interestingly, by also removing the
N-terminal section involved in oligomerization of CsxA
monomers, a narrow product distribution was obtained, which
may find application in vaccine development.
Polysialic acid (polySia, structure G in Figure 2) chains with
lengths of up to 400 sialic acid residues are important
constituents of the CPS of certain Gram-negative bacteria and
serotypes, including Neisseria meningitidis, Escherichia coli,
Moraxella nonliquefaciens, and Mannheimia haemolytica (Mh).
Bacterial polysialyltransferases (PSTs) are classified in GT
family 38 and are able to construct homopolymers of α-2→ 8-
linked (as in E. coli K1 andN. meningitidis serogoup B) or α-2→
9-linked sialic acids (as in N. meningitides serogroup C), or
heteropolymers of alternating α-2→ 8/α-2→ 9-linked residues,
all on a β-Kdo-lipid precursor.52 Interestingly, mammalian PSTs
belong to GT family 29 and solely produce homopolymers of α-
2 → 8-linked sialic acids linked to proteins, such as neural cell
adhesion molecule (NCAM). Because these polySia chains are
central carbohydrates in eukaryotic cell−cell signaling in the
brain and during embryonic development, the bacterial polySia
capsules successfully evade the immune system. On the one
hand, this molecular mimicry hampered the application of
vaccines generated against these bacterial polySia capsules, but it
was successfully exploited to improve the pharmacokinetic
properties of human therapeutic proteins by decorating them
with poly-α-2 → 8-Sia chains through the action of bacterial
PSTs.56 A comparison of structural data of MhPST and a
mammalian PST (ST8SiaIII) revealed that, although both
enzymes create the same type of α-2→ 8-linked polySia chains,
the enzymes share no common structural features.57 InNeisseria
meningitidis serogroups B (NmB) and C (NmC) and Escherichia
coli K1, the polySia in the capsule is essential for virulence,
making the polySia-producing enzymes a potential antimicrobial
target. The structural differences between the bacterial and
mammalians PSTs, leading to higher substrate promiscuity for
the first, may aid in selective inhibitor development.58
Contradicting reports exist on the degree of processivity
displayed by the PSTs, which may be explained by their different
origins or the different conditions used in the experiments. The
latter reason is especially apparent for the bacterial PSTs, which
are membrane-bound enzymes. Reaction conditions, including
the method to solubilize the membrane-bound enzyme and
acceptor lipid, seem to have a major impact on the reaction
kinetics and product length distributions. When a soluble
truncated NmBPST construct was used to elongate a
trisialoganglioside acceptor, a product pattern consistent with
a distributive mechanism was observed by HPLC analysis.59 A
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similar conclusion was derived for the NmC homologue upon
successful distraction of a running reaction with an unnatural
acceptor.60 Alternatively, in an in vivo experiment, in which the
expression of EcPST was induced in the absence of endogenous
PST activity, a processive mechanism was postulated on the
basis of the product distribution (visualized with TLC
analysis).61 Moreover, when EcK92PST was solubilized in
native membranes, the shorter product lengths (DP < 10)
suggest a distributive mechanism, whereas the larger polySia
chains (DP > 12) are rapidly elongated to form the full-length
poly-Sia.62 This latter finding suggests an increasing product
affinity upon elongation that induces an increase in the degree of
processivity. Bacterial PSTs are postulated to be part of a large
biosynthetic complex in vivo, also containing translocation
machinery that may assist in exporting the growing poly-
saccharide. Since processivity has been coupled to translocation
in other well-studied systems including cellulose synthesis,27 the
processivemechanismmay become apparent in more in vivo-like
experimental systems.
Information on the degree of processivity can also be obtained
by structural analyses and binding studies. STD-NMR studies
with full-length NmBPST suggested an extended acceptor
binding site that can accommodate up to six Sia residues.63 In
addition, crystallographic analysis of the MhPST reveals a deep
electropositive groove in between the two Rossmann-fold
domains that binds the acceptor mimetic fondaparinux in the
open state.57 It is postulated that the active site closes during
catalytic activity to retain the polyanionic growing chain,
suggesting a processive mechanism. The importance of acceptor
binding for the degree of processivity was highlighted in a
seminal contribution by the group of Gerardy-Schahn.64 Using a
neutral genetic drift approach to quickly engineer NmBPST
variants, a single amino acid in the acceptor-binding domain was
identified that could toggle the mechanism between processive
and distributive (product profiles analyzed by HPLC). More-
over, a number of basic residues were identified in the acceptor-
binding site that were individually contributing to the increased
processivity, suggesting their importance in binding the growing
polySia chain. This is a great example of how in-depth structural
studies contribute to understanding the underlying reasons for
processivity and allow to manipulate and tune the mechanism of
the enzyme, depending on the application in mind. Moreover, it
highlights the importance of studying and exploiting processivity
and its determinants as a way to expand the enzymatic toolbox.
Lipopolysaccharide O-Antigens. O-Antigens are long
polysaccharide motifs that are covalently attached to the
lipopolysaccharide (LPS) molecules in most Gram-negative
bacteria (structure H and I in Figure 2).65 They consist of one or
multiple types of monosaccharides and provide a great structural
diversity to the extracellular glycocalyx of bacteria. There are
three different pathways through which the O-antigens may be
biosynthesized, which are primarily characterized by the
translocation machinery: the Wzy-dependent pathway, the
synthase-dependent pathway, and the ATP-binding cassette
(ABC)-transporter-dependent pathway.66 The Wzy polymerase
is found to act in a nonprocessive (distributive) manner, while
the other two generally are involved in processive elongation.67
O-antigens are generally synthesized on the cytosolic side of the
inner membrane, as is the Lipid A core, after which they are
ligated in the periplasm. It has been suggested that the
polymerization of O-antigen is halted by this ligation event,
leading to a modal distribution of O-antigen lengths specific to
bacterial species and even serotypes.
Salmonella enterica serogroup O:54 produces an O-antigen
that consists of ManNAc residues alternately connected through
β-1→ 3 and β-1→ 4 linkages in a synthase-dependent pathway
(structure H in Figure 2). The O-antigen synthesis starts by the
addition of a single ManNAc unit to an undecaprenol-
pyrophosphate-GlcNAc acceptor by the monofunctional
WbbE (RfbA). Next, the acceptor is elongated at the
nonreducing end by WbbF (RfbB, GT family 2) using a
processive mechanism, which is proposed by sequence similarity
to other processive transferases.68,69 As synthases are integral
membrane proteins, WbbF is predicted to simultaneously
perform glycosyl transfer and translocation of the growing
chain, as a mechanism to support processivity. Currently,
molecular details of the structural determinants underlying this
mechanism remain elusive.
An example of processive O-antigen synthesis through the
ABC-transporter-dependent pathway is the construction of D-
galactan I from Klebsiella pneumoniae, which is composed of [3-
β-D-Galf-(1 → 3)-β-D-Galp-(1 →] disaccharide repeats
(structure I in Figure 2). The Und-PP-GlcNAc acceptor is
first elongated with Galp and Galf by bifunctional WbbO and
subsequently elongated by both WbbO and WbbM at the
nonreducing end of the lipid-linked acceptor substrate using
nucleotide-activated donors. Kinetic experiments suggest that
both enzymes are involved in the processive synthesis of D-
galactan I, as no products of intermediate lengths are observed
(judged by the level of incorporation of radioactivity).70 Further
studies that generate a more detailed picture (e.g., product
profiles, kinetic, and binding studies) are needed to provide solid
proof of processivity and unravel the enzymatic determinants
that result in this processive behavior.
Mycobacterial (Arabino)galactan.Themycobacterial cell
wall contains a linear polymer of 20−40 galactofuranose (Galf)
units termed the galactan (structure K in Figure 2). Because of
its important role in cell wall maintenance and survival of
Mycobacteria, the biosynthesis of (arabino)galactan is of high
interest.71 The bifunctional enzyme GalfT2 uses a single active
site72 to produce galactan with alternating β-1→ 5 and β-1→ 6
linkages by adding Galf units (from UDP-Galf) to the
nonreducing end of a decaprenyl-pyrophosphate-linked
GlcNAc-Rha-Galf-Galf as the acceptor tetrasaccharide.73,74
Kiessling and co-workers obtained initial hints that GalfT2 is a
processive enzyme by the remaining presence of the lipid-linked
acceptor while products with 3−27 added Galf units were
produced.75 Moreover, when the reaction was performed with
the glycolipid acceptor in 1000-fold excess over the enzyme, the
elongated products were observed even at the earliest time
points, suggesting that the enzyme stays associated with the
product to perform multiple rounds of catalysis. Chemical
synthesis gave access to a selection of lipids varying in length,
and only the longer lipids showed processive elongation in vitro,
suggesting a high affinity for the lipid moiety in a tethering
mechanism.75 Additionally, X-ray crystallography studies
revealed that GalfT2 forms a homotetramer that associates
with the membrane, so that the lipid acceptor may freely bind to
and dissociate from both the enzyme and lipid bilayer.76
Subsequently, processivity was further proven by a distraction
assay under single-hit conditions (i.e., a large acceptor substrate
to enzyme ratio).77 The GalfT2 reaction was started in the
presence of the regular acceptor substrate, followed by the
addition of an isotopically labeled acceptor. After a second
period, the product distribution was analyzed by MALDI-TOF,
and this analysis revealed that most isotopically labeled acceptor
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was elongated with only a few Galf units, while the long Galf
polymers were attached to the regular acceptor. The effort to
elucidate the mechanism of GalfT2 is an exemplary case where
multiple methods are used to unequivocally conclude
processivity: product distribution studies and single-hit and
distraction assays revealed continuous association of the enzyme
and substrate, while structural studies showed tethering and
membrane association.
■ SEMIPROCESSIVITY IN POLYMERIZING
GLYCOSYLTRANSFERASES
An unusual class of processive GTs is formed by the enzymes
that catalyze a limited number of glycosyl transfers processively,
before they release the product. Such enzymes are identified as
semiprocessive, and they may display both processive and
distributive characteristics. For example, in Campylobacter jejuni
N-glycan synthesis, a trisaccharide is assembled on an
undecaprenol-diphosphate anchor in the membrane and
subsequently elongated by the action of PglH (Figure 4A).78
This enzyme transfers three N-acetylgalactosamine units
sequentially without releasing the growing substrate in a
semiprocessive manner, as determined by radiolabeled product
profiles (HPLC). Kinetic studies indicated that the first and
second GalNAc addition are fast and that the binding affinity of
PglH for the glyco-products increases with every GalNAc
addition. Recent structural studies of PglH bound to a lipid-
linked product analogue revealed that after the transfer of three
GalNAc residues, the pyrophosphate moiety at the reducing end
is pushed to make contacts with positively charged residues in
the potential “ruler helix”.79 This interaction is suggested to
inhibit subsequent sliding of the product which would be needed
for the transfer of additional GalNAc residues, and as a result, the
product is released after three GalNAc additions. In this case, it
is apparent that the increasing affinity for modified substrate is a
determinant of processivity, whereas the structural control of
trisaccharide release is a distributive feature. A combination of
these traits results in semiprocessivity.
In the Mycobacterial galactan synthesis, the processive action
of GlfT2 (vide supra) is preceded by the sequential addition of
two Galf residues to decaprenyl-pyrophosphate-linked GlcNAc-
Rha disaccharide by GlfT1 to create the tetrasaccharide acceptor
substrate.74,80 In vitro experiments suggest the processive
addition of two Galf units, since the single addition-product is
not observed (MALDI-TOF), but more experiments are needed
to confirm processivity of GlfT1.81 Other bacterial GTs that
transfer residues iteratively include WaaA (formerly KdtA) in E.
coli, which is involved in the transfer of two Kdo residues in the
synthesis of Lipid A.82 Interestingly, WaaA homologues in
Chlamydia species can be also tri- and tetrafunctional, whereas
homologues have been identified that just transfer a single Kdo
residue.65 It is interesting to investigate whether these Kdo
residues are added using a processive or distributive mechanism
and how length control is established.
Eukaryotes also harbor semiprocessive GTs, such as Alg2 and
Alg11 from Saccharomyces cerevisiae, which are both involved in
N-glycan synthesis on the cytosolic face of the ER (Figure 4B).
Interestingly, Alg2 is a bifunctional enzyme that attaches α-1→
3 and α-1→ 6 linked mannosides consecutively to the dolichol-
pyrophosphate-GlcNAc2Man acceptor, as identified by HPLC
analysis of the glycan products.83,84 Subsequently, this lipid-
linked pentasaccharide is further elongated by the sequential
addition of two α-1 → 2 mannosides by Alg11.84,85 Whereas
intermediate products (i.e., after a single mannosylation event)
have not been observed for both enzymes, the definite proof for
a processive mechanism has not yet been provided.
■ PROCESSIVITY IN PROTEIN
GLYCOSYLTRANSFERASES
Selected families of eukaryotic and bacterial proteins are found
to be heavily modified with various sugars resulting in a
hyperglycosylated protein surface. In bacteria, these proteins
include adhesin proteins, autotransporters, pili, and flagella,
which are involved in pathogenic traits such as adhesion to host
cells and provide motility, physical insertion in the mucus layer,
and resistance to shear stress. In the examples known to date,
hyperglycosylation is achieved via the action of a single or
multiple cytoplasmic glycosyltransferases that use nucleotide-
activated monosaccharides to directly modify their protein
substrates. Intriguingly, protein hyperglycosylation may also be
performed in a processive manner and identifying the degree of
processivity will be important to develop strategies to inhibit this
hyperglycosylation.
Well-known examples of hyperglycosylated adhesin proteins
are the serine-rich repeat proteins (SRRPs) in Gram-positive
Streptococcal, Staphylococcal, and Lactobacilli species, where
SRRPs are responsible for adhesion and/or biofilm formation.
Examples of these hyperglycosylated adhesion virulence factors
include Srr1 from Streptococcus agalactiae,86,87 Fap1 from
Streptococcus parasanguinis,88 PsrP from Pneumococcal spe-
cies,89,90 GspB (structure B in Figure 2) and Hsa from
Streptococcus gordonii, and Srap from Staphylococcus aureus.88
The first step of multisite O-GlcNAcylation in the Ser/Thr-rich
domain is catalyzed by the GtfA/GtfB enzyme complex (also
termed Gtf1/Gtf2), and it provides the basis for further
modification and glycan diversification. GtfA is a glycosyl-
transferase (GT family 4) and GtfB is an associated chaperone
responsible for the stability of the complex and it conveys affinity
for the protein substrate and glyco-intermediates.91,92 Recently,
the first crystal structure of the GtfA/GtfB complex was
published, together with data from kinetic and binding
experiments.92 An in vitro activity assay of the GtfA/GtfB
complex from Streptoccocus gordonii with truncated versions of
the GspB adhesin substrate showed a distinct two-step
mechanism of glycosylation (gel electrophoresis). In the first
“fast” phase, an accumulation of glyco-intermediates of varying
degrees of O-GlcNAc-modification was observed (gel electro-
phoresis), which were transformed into fully glycosylated
products in the second “slow” phase, suggesting a distributive
mechanism. Moreover, when the reaction was diluted to prevent
Figure 4. Schematic overview of semiprocessive PglH (A) and Alg2 and
Alg11 (B).
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reassociation (single-hit conditions), the GtfA/GtfB reaction
did not proceed. It will be interesting to investigate the
mechanistic features of the functional homologues of GtfA/GtfB
in other species.
Hyperglycosylation has also been identified in ClfA
(clumping factor A) in Staphylococcus aureus, which is one of
the ESKAPE pathogens and a difficult Gram-positive pathogen
to combat due to the complex network of virulence factors.
Among the identified surface proteins of Staphylococcus aureus,
ClfA is heavily modified with O-GlcNAc moieties, which
mediate attachment to host cells and evasion from the host
immune system.93 The first step of hyperglycosylation is
performed by SdgB, which adds GlcNAc units to the serine
residues in serine-aspartate dipeptide-repeats (SDR). Next, the
majority of O-GlcNAc moieties is decorated by an additional
GlcNAc by the action of SdgA transferase, resulting in a
disaccharide motif. Mass analysis of in vitro glycosylation
reactions on the purified SDR-region (expressed as soluble
construct) revealed that 59 GlcNAc units are added by SdgB,
followed by an additional 47 units by SdgA, with no detectable
intermediate products. This may suggest some degree of
processivity, but a detailed kinetic investigation is warranted
to provide additional proof.
One of the early examples of extensive protein asparagine-
glycosylation in Gram-negative bacteria was identified in
nontypeable Haemophilus inf luenzae (NTHi), where HMWA
(high-molecular weight) adhesin proteins were found to be
highly N-glycosylated with single glucose units by their cognate
HMW1C glycosyltransferase.94,95 Preliminary results from our
group hint at some degree of processivity for HMW1C and its
structural and functional homologue from Actinobacillus pleuro-
pneumoniae. By utilizing intact protein mass spectrometry to
monitor progression of glycosylation over time, complemented
with a distraction assay, affinity studies and proteomics, we were
able to visualize the kinetic behavior of Ap/Hi-HMW1C-
catalyzed hyperglucosylation. Our data suggests processive
behavior for these enzymes at certain stages of the reaction,
and we are currently investigating the rationale behind these
findings.
Gram-negative bacteria also may display another family of
adhesins called the autotransporter proteins. They possess a C-
terminal beta-barrel domain and a variable N-terminal passenger
domain that allow them to perform self-transport as well as
adhesion functions, respectively.96 One of the most prominent
examples is the family of self-associating autotransporters
(SAAT) from E. coli species. Members of this group include
AIDA-I (adhesin involved in diffused adherence), the TibA
autotransporter (structure J in Figure 2), and aggregation factor
Ag43. All three proteins are modified with heptosides on
multiple Ser/Thr sites by the action of associated transferases
(Aah96 and TibC97), which are also functionally interchange-
able.98 Similar to other O-glycosylation machinery, these
transferases lack a conserved amino acid recognition sequence
but instead rely on structural motifs for recognition, as was
discovered in the studies of the Aah transferase.99 Interestingly,
both Aah and TibC belong to the dodecameric iron-containing
family of enzymes. It was shown that the architecture in which
the 12 subunits form two stacked six-membered rings is
important for its mechanism,97 as only the inside of the ring
was performing catalysis, modifying six molecules of substrate
simultaneously in a so-called “screw-propelling” mechanism.
The mechanism of TibA hyperheptosylation was therefore
hypothesized to include processive features. This is also in line
with the “crowding reasoning” which suggests that processive
modifications are preferred over distributive ones in confined
environments due to subdiffusion.100 However, kinetic experi-
ments are needed to further validate the postulated hypothesis of
TibC/Aah processivity. Other examples of hyperglycosylated
adhesins are identified in enterotoxigenic Escherichia coli (EtpA,
TPS adhesin),80 Kingella kingae (KnH autoransporter), and
Aggregatibacter aphrophilus (EmaA autotransporter), but the
mechanisms of the responsible GTs remain elusive.
As apparent from the examples above, the first data on
processivity in protein glycosyltransferases is currently starting
to appear. Processivity is a complex mechanistic trait to
investigate, especially in glycoproteins that are larger in size,
and it requires thorough investigation using different methods to
draw solid conclusions. An example of such a thorough approach
in protein glycosylation is the research on the distributive
character of the mammalian O-GlcNAc transferase.101 In
examples that currently lack concrete evidence, additional
steps can be taken to solidify the conclusions. For instance, a
distraction assay with (labeled) protein substrate can be used to
prove processivity of the S. aureus SdgB and SdgA glycosyl-
transferases. In the case of TibC/Aah, monitoring the reaction
for intermediates and determining the kinetic parameters will
further add to existing structural evidence of processivity. These
and other experiments will be important to elucidate the
mechanism of protein hyperglycosylation in pathogenic
bacteria.
■ PROCESSIVITY AND INHIBITOR DESIGN
Knowledge of specific mechanistic features, such as the catalytic
residues, structure of the transition state, and metal ion
involvement, is generally a good starting point for rational
drug design.22 Additionally, determining the enzyme structure
with substrate or inhibitor bound is useful to avoid targeting
eukaryotic GTs in the same fold family. Especially when the
enzyme acts on a unique bacteria-specific carbohydrate residue,
knowledge of its binding may provide handles for specificity.
The (degree of) processivity can become an additional asset, as
processivity often stems from specific mechanistic or structural
elements that can be exploited in enzyme-specific inhibitor
design. In contrast, designing (competitive) inhibitors for
processive enzymes may be complicated by the high affinity
for their substrates and the presence of additional binding
pockets and translocation machinery.
To the best of our knowledge, a few examples exist where
determinants of processivity are exploited in inhibitor design. In
the case of GalfT2 from Mycobacteria, processivity inspired the
generation of disaccharide-like inhibitors. The enzyme prefers
elongating a Galf-Galf motif, and these disaccharide analogues
were shown to inhibit moderately at mM concentrations.102 As a
Galf-trisaccharide is an even better acceptor,103 increasing the
size of the inhibitors to trisaccharide analogues may increase the
inhibitory potency. To inhibit peptidoglycan synthesis that
occurs at the membrane interface, lipid-linked GlcNAc-
MurNAc derivatives were produced as inhibitors for peptido-
glycan transferase,104 These Lipid II analogues showed good
inhibition of PG transferase in vitro and are postulated to be
good binders to both the donor and acceptor binding sites.
Furthermore, in experiments inspired by the hydrophobic
acceptor-binding groove in bacterial cellulose synthase BcsA,
donor analogues that are extended on the uridine moiety with
aromatic residues gave decent IC50 values.
105 These examples
serve to showcase that understanding the mechanistic character-
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istics and determinants of processivity may pave the way for
specific processivity-targeted inhibitors.
■ CONCLUSIONS
Processivity is a mechanistic trait that is highly challenging to
study. Analysis of the enzymatic reaction in terms of product
distribution and kinetics and the use of experimental tricks like
single-hit conditions or acceptor substrate distraction informs
on the degree of processivity. One must recognize that
processivity is not a singular enzymatic property, but rather a
continuum of possibilities that are system-dependent. Strictly
processive (or distributive) enzymes display an array of
recognizable features (listed in Figure 5) that can be determined
using methods described in this Review. However, researchers
must exercise caution when interpreting experimental evidence,
as in certain examples it might be misleading rather than
informative. For instance, structural features such as the
presence of large or tight substrate binding grooves, the
presence of a kinetic lag phase, or a (quasi)-monodisperse
product profile might suggest processivity, but can instead be
intrinsic features of certain enzymes that are distributive in
mechanism. For instance, the teichoic acid polymerase TagF has
a large open active site that would allow continuous binding of
CDP-glycerol-β-phosphate donor and release of CMP by-
product during polymerization. However, it was found that the
polymerization of glycerol phosphate is instead concentration-
dependent and is catalyzed in a “non-continuous manner”, i.e.
distributively.106 Furthermore, in the case of the class II
hyaluronan synthase from Pasteurella multocida, a kinetic lag
phase was observed at early stages of the reaction. However, by
monitoring the polymerization reaction by TLC a ladder of
products was observed, indicating a stepwise (distributive)
mechanism.107 Moreover, the quasi-monodisperse (processive-
like) product profile only appeared when an oligosaccharide
acceptor was used in the reaction.108,109 Also external factors
may play a role in the perceived processivity, as the lack of
“native” conditions (e.g., the natural enzyme/substrate concen-
tration or the presence of membrane translocation machinery)
in in vitro reactions can influence the experiment tremendously.
Mentioned in this Review are also semiprocessive enzymes that
often possess a complex mechanistic profile with several
distinctive features of both processivity and distributivity.
Consequently, multiple carefully designed experiments are
imperative to conclude the processivity (or lack thereof) in
more challenging cases where conflicting evidence makes it
difficult to place the enzyme under investigation on either side of
the spectrum.
Many GTs suspected of processive catalysis still remain to be
investigated. For instance, wall teichoic acid glycosylation in
methicillin-resistant Staphyloccocus aureus (MRSA) is performed
by TarP.110 In analogy to TarM and TarS in the nonresistant
strains, TarPmay also display processive character. Additionally,
in the case of protein glycosylation in MRSA, SDR (serine-
aspartate repeats)-containing Pls (plasmin-sensitive protein)
was recently discovered to be heavily glycosylated, which was
important for (in vitro) biofilm formation.111 Glycosylation is
performed by the action of four glycosyltransferases, namely
GtfC, GtfD, SdgA, and SdgB. As the latter two have been shown
to act in a processive manner (vide supra), it is interesting to
extrapolate these studies to GtfC/GtfD. In all, it is important to
dedicate efforts toward understanding bacterial glycosyltransfer-
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■ KEYWORDS
Processivity: the ability to remain associated with the
growing substrate in between rounds of catalysis. This results
in a predominant formation of highly modified products,
while starting substrate may remain.
Distributivity: the fact that the enzyme dissociates after each
catalytic reaction, resulting in a distribution of products.
Semiprocessive: a mechanistic trait that results in a limited
number of catalytic reactions in a processive way, followed by
enzyme dissociation.
Apparent processivity: the degree of processivity displayed
by an enzyme under specific conditions, e.g. concentration
and nature of the substrate, or the presence of membrane
translocation machinery.
Intrinsic processivity: the distribution of probabilities that
an enzyme will stay associated and catalyze another reaction
or dissociate from the intermediate product.
Hyperglycosylation: addition of multiple carbohydrate
moieties to the surface of a protein.
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